Serious adverse events | | | |
Overall | 3 (2.9) | 4 (4.0) | 0.72 |
Life-threatening myocardial infarctionc | 0 (0.0) | 1 (1.0) | — |
Hospitalisation for lower back pain | 1 (1.0) | 0 (0.0) | — |
Hospitalisation for atrial fibrillationc | 0 (0.0) | 1 (1.0) | — |
Hospitalisation for epistaxis | 0 (0.0) | 1 (1.0) | — |
Hospitalisation for renal calculi | 1 (1.0) | 0 (0.0) | — |
Hospitalisation for lung infection | 1 (1.0) | 0 (0.0) | — |
Hospitalisation for hyperglycaemia | 0 (0.0) | 1 (1.0) | — |
|
Adverse events (Antidepressant Side-Effect Checklist at week 14) | | | |
Any adverse events | 88 (86.3) | 97 (98.0) | 0.001 |
Largest differences | | | |
Dry mouth | 52 (51.0) | 86 (86.9) | <0.001 |
Constipation | 31 (30.4) | 58 (58.6) | <0.001 |
Sweating | 21 (20.6) | 31 (31.3) | 0.033 |
Sexual dysfunction | 9 (8.8) | 17 (17.2) | 0.084 |
Headache | 27 (26.5) | 14 (14.1) | 0.009 |
Diarrhoea | 21 (20.6) | 11 (11.1) | 0.060 |